Neurogene (NGNE) Tops Q2 EPS by 38c

Neurogene (NASDAQ: NGNE) reported Q2 EPS of ($1.05), $0.38 better than the analyst estimate of ($1.43).

For earnings history and earnings-related data on Neurogene (NGNE) click here.

You May Also Be Interested In

• Core & Main, Inc (CNM) Tops Q3 EPS by 2c ; Offers Guidance
• Maxim Group Downgrades Campus Crest Communities (CCG) to Hold
• Atlas Lithium contracts 71% of Neves Project capital budget below estimates